Drugs / SLS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00967174 | May → Jun 2005 | — | McNeil AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SLS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00967174 ↗ |
| Route | Topical | “0.1% (w/v) SLS patch applied on the lower back, according to treatment sequence, daily for 21 days.” NCT00967174 ↗ |